Description

1,2,4-Triazolo(3,4-A)Phthalazine, 3-(3,5-Dibromo-2-Ethoxyphenyl)-6-(1- Pyrrolidinyl)- is a specialized heterocyclic organic compound featuring a fused triazolophthalazine core with brominated aryl and pyrrolidinyl substituents. This complex molecular architecture makes it a valuable advanced pharmaceutical intermediate and a key building block for research into novel bioactive molecules. It is primarily sought by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the synthesis of new chemical entities, particularly for applications in medicinal chemistry and agrochemical discovery.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders or possessing potential anti-inflammatory or anti-cancer properties.
• Medicinal Chemistry Research: Serves as a sophisticated scaffold for structure-activity relationship (SAR) studies and high-throughput screening in drug discovery programs.
• Agrochemical Development: Used in the research and development of new pesticides or herbicides, leveraging its heterocyclic structure for biological activity.
• Organic Synthesis Building Block: Employed in academic and industrial research for constructing complex polyheterocyclic systems due to its reactive functional groups.
• Material Science Research: Investigated as a potential component for organic electronic materials or as a ligand in catalytic systems, given its conjugated structure and nitrogen-rich composition.

Basic Information

Item	Details
Product Name	1,2,4-Triazolo(3,4-A)Phthalazine, 3-(3,5-Dibromo-2-Ethoxyphenyl)-6-(1- Pyrrolidinyl)-
CAS No.	87540-17-8
Molecular Formula	C21H19Br2N5O
Molecular Weight	517.22 g/mol
Synonyms	3-(3,5-Dibromo-2-ethoxyphenyl)-6-(pyrrolidin-1-yl)-[1,2,4]triazolo[3,4-a]phthalazine; 6-(1-Pyrrolidinyl)-3-(3,5-dibromo-2-ethoxyphenyl)-1,2,4-triazolo[3,4-a]phthalazine; 87540-17-8; 3-(3,5-Dibromo-2-ethoxyphenyl)-6-(1-pyrrolidinyl)-1,2,4-triazolo[3,4-a]phthalazine; [1,2,4]Triazolo[3,4-a]phthalazine, 3-(3,5-dibromo-2-ethoxyphenyl)-6-(1-pyrrolidinyl)-
EINECS	Contact for details

Quality Control

Our production of this high-value intermediate adheres to strict quality management systems. Every batch is characterized and tested to ensure identity, purity, and consistency, meeting the exacting standards required for pharmaceutical and advanced research applications. A comprehensive Certificate of Analysis (COA) is provided with each shipment, detailing key parameters such as assay purity and impurity profiles as determined by HPLC, NMR, and mass spectrometry.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). The compound is light-sensitive; prolonged exposure to light should be avoided to maintain stability.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (HPLC/MS)	Conforms
Identification (NMR)	Conforms
Assay (HPLC)	≥ 97.0%
Purity (HPLC, Area %)	≥ 98.0%
Single Maximum Impurity	≤ 1.0%
Residual Solvents (GC)	Meets ICH guidelines
Loss on Drying	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.